Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (441-450 of 626) with videos related to

Pageof 63
Sort By:
The Journal of Biological Chemistry|October 29, 2010
STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammationFabrice Moore, Najib Naamane, Maikel L Colli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 24, 2026
The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerationsRenald Meçani, Taulant Muka, Monika Cigler, et al.
Diabetes Care|July 14, 2017
Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and <i>HLA-DQ</i> Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 DiabetesFrans K Gorus, Eric V Balti, Anissa Messaaoui, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2018
Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World StudySara Charleer, Chantal Mathieu, Frank Nobels, et al.
Diabetes Care|June 10, 2019
Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 DiabetesBruce A Perkins, Julio Rosenstock, Jay S Skyler, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 28, 2020
Effect of Intravenous 25OHD Supplementation on Bone Turnover and Inflammation in Prolonged Critically Ill PatientsCatherine Ingels, Ilse Vanhorebeek, Sophie Van Cromphaut, et al.
Diabetes, Obesity & Metabolism|November 4, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studiesMoshe Phillip, Chantal Mathieu, Marcus Lind, et al.
The Lancet Regional Health. Europe|February 12, 2026
Diabetes community calls for quality standards for continuous glucose monitoring devicesFrancesco Giorgino, Tadej Battelino, Stefano Del Prato, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitusJacques Pirenne, Koen Deloose, Willy Coosemans, et al.
Transplantation|May 21, 2020
Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes PatientsDaHae Lee, Pieter Gillard, Robert Hilbrands, et al.
Pageof 63

Showing results (441-450 of 626) with videos related to

Sort By:
Pageof 63
The Journal of Biological Chemistry|October 29, 2010
STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammationFabrice Moore, Najib Naamane, Maikel L Colli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 24, 2026
The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerationsRenald Meçani, Taulant Muka, Monika Cigler, et al.
Diabetes Care|July 14, 2017
Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and <i>HLA-DQ</i> Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 DiabetesFrans K Gorus, Eric V Balti, Anissa Messaaoui, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2018
Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World StudySara Charleer, Chantal Mathieu, Frank Nobels, et al.
Diabetes Care|June 10, 2019
Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 DiabetesBruce A Perkins, Julio Rosenstock, Jay S Skyler, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 28, 2020
Effect of Intravenous 25OHD Supplementation on Bone Turnover and Inflammation in Prolonged Critically Ill PatientsCatherine Ingels, Ilse Vanhorebeek, Sophie Van Cromphaut, et al.
Diabetes, Obesity & Metabolism|November 4, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studiesMoshe Phillip, Chantal Mathieu, Marcus Lind, et al.
The Lancet Regional Health. Europe|February 12, 2026
Diabetes community calls for quality standards for continuous glucose monitoring devicesFrancesco Giorgino, Tadej Battelino, Stefano Del Prato, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitusJacques Pirenne, Koen Deloose, Willy Coosemans, et al.
Transplantation|May 21, 2020
Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes PatientsDaHae Lee, Pieter Gillard, Robert Hilbrands, et al.
Pageof 63